Nice work from @AbhiDuggalMD@l_bulgarelli@rod_deliberato@a_serpaneto et al.
ARDS subphenotypes predict risk & show that neuromuscular blockers shouldn’t be used routinely—signal of benefit only in hypoinflammatory (A); none in hyperinflammatory (B).
https://t.co/UZEPCvU9s0
Subphenotyping ARDS is racing ahead! 🏎️
1️⃣ subphenotypes defined
2️⃣ associated w outcomes
3️⃣ found heterogeneity of treatment effect
…and now, @msiuba et al look at association w diff R ❤️ & PA physiology!
https://t.co/wsF25PZVNJ
#journal_CHESTCritCare#OpenAccess
"@united Why can't your agents at least try to call IAD when there's a maintenance delay from CVG to check if I will have time to make my international flight ? Instead, my flight was rescheduled, making me lose a day of my trip. This is very inconvenient."
Not at #ATS2024, but relevant.
Hot off the press @journal_CHEST and open access!
"Differential Effect of PEEP Strategies in ARDS Patients: A Bayesian Analysis of Clinical Subphenotypes"
https://t.co/hLLxWUqEkp
@a_serpaneto